How a $250,000 Tx can End Up Costing $2+ Million
Today we now better understand how UBER costly drugs, such as the big-ticket CAR-T therapies, are billed and paid for in our highly fractional health
Today we now better understand how UBER costly drugs, such as the big-ticket CAR-T therapies, are billed and paid for in our highly fractional health
Over the years I’ve been able to visit dozens of specialty pharmacies working with pharmacy leadership to help develop new programs. Each of these new
How time flies!About three years ago Amazon jumped into the prescription business throwing a new monkey wrench in the segment. So, what’s happened in that
Were there fireworks to mark the event?Was there a parade to commemorate the long-awaited day?In short, NO! Annual Drug Trend Reports from Express Scripts (Evernorth)
The FDA approved a new infused specialty therapy last week, Zynlonta (loncastuximab tesirine-lpyl) from ADC Therapeutics, for the treatment of adult patients with relapsed or
We’ve ranted about the encroachment of hospital and health system owned specialty pharmacies more times that one can count. The growth of these organizations seemed
Last week the FDA approved a new specialty therapy, Jemperli (dostarlimab) from GlaxoSmithKline, for treating patients with recurrent or advanced endometrial cancer. Uterine cancers are
The article below details a new PSAO option for pharmacies, the ‘first’ PSAO for community-based specialty pharmacies from AmerisourceBergen named the Accelerate Specialty Network. Network
White bagging is back in the news and is increasingly being used by hospitals and health systems as a weapon to demonize emerging models for
So, when was the last time your company looked at its protocols to safeguard Protected Health Information (PHI)? You know, all that patient-specific information that